Search - tctmd.com

Displaying 941 - 960 of 1072

Sort: Relevancy | Date

News Daily News

STS Meeting Looks at New TAVR Device and Reviews Valve Procedure Rates in the UK

Jason Kahn

January 28, 2013

News Industry News

Direct Flow Medical® Receives CE Mark for Transcatheter Aortic Heart Valve System That Virtually Eliminates Aortic Regurgitation

January 27, 2013

News Daily News

European Registry: TAVR Devices Show Similar Short-, Long-term Outcomes

Caitlin E. Cox

January 16, 2013

News Daily News

Percutaneous Device-Based Closure Successful in Children with Ventricular Septal Defects

L.A. McKeown

November 14, 2012

News Conference News TCT 2012

TAVR Feasible for Inoperable Patients with Severe Regurgitation Alone

October 31, 2012

News Industry News

First Results from Medtronic Engager™ European Pivotal Trial Demonstrate Positive Outcomes

October 29, 2012

News Conference News TCT 2012

Repositionable Valves Found Safe, Effective in Two Trials

October 24, 2012

News Conference News TCT 2012

Registries Show TAVR Evolution in UK, Internationally

October 24, 2012

Presentation TCT 2012

Endoluminal Sciences: A New Concept for Eliminating Paravalvular Regurgitation

Presenter: Raj Makkar

October 24, 2012

Presentation TCT 2012

A Novel Balloon-Expandable TAVR System for Aortic Regurgitation

Presenter: Jian Ye

October 24, 2012

Presentation TCT 2012

TCT-97. Three-dimensional Echocardiographic Measurements of the Aortic Annulus Predict Paravavular Regurgitation Following Transcatheter Aortic Valve Replacement

Presenter: Rebecca Hahn

October 23, 2012

Presentation TCT 2012

TCT-92. Does Mitral Regurgitation Impact the Outcome of TAVI Procedures? Insights from the FRANCE2 Registry

Presenter: Eric van Belle

October 23, 2012

Presentation TCT 2012

TCT-91. Peri-valvular Aortic Regurgitation in Balloon-expendable and Self-expendable TAVI procedures: Predictors and Impact on Clinical Outcome - Insights from the FRANCE2 Registry

Presenter: Eric van Belle

October 23, 2012

News Industry News

Neovasc's Tiara™ transcatheter mitral valve selected as a best new device concept at TCT 2012 Scientific Symposium

October 23, 2012

News Industry News

Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami

October 23, 2012

Presentation TCT 2012

Reduces Paravalvular Regurgitation

Presenter: Benoit Daneault

October 22, 2012

Presentation TCT 2012

Paravalvular Regurgitation as a Strong Predictor of Post-TAVR Mortality

Presenter: Susheel Kodali

October 22, 2012

Presentation TCT 2012

Moderate or Severe Mitral Regurgitation and Aortic Stenosis: Surgery or TAVR?

Presenter: John Webb

October 22, 2012

Presentation TCT 2012

3-D Annulus Sizing (using MSCT or 3-D Echo) Is Now the Gold Standard and Helps to Reduce Paravalvular Regurgitation After TAVR

Presenter: Hasan Jilaihawi

October 22, 2012

News Conference News TCT 2012

Review of TAVR Use Offers Significant Advances, Positive Outcomes

October 22, 2012

Advertisement

STS Meeting Looks at New TAVR Device and Reviews Valve Procedure Rates in the UK

Direct Flow Medical® Receives CE Mark for Transcatheter Aortic Heart Valve System That Virtually Eliminates Aortic Regurgitation

European Registry: TAVR Devices Show Similar Short-, Long-term Outcomes

Percutaneous Device-Based Closure Successful in Children with Ventricular Septal Defects

TAVR Feasible for Inoperable Patients with Severe Regurgitation Alone

First Results from Medtronic Engager™ European Pivotal Trial Demonstrate Positive Outcomes

Repositionable Valves Found Safe, Effective in Two Trials

Registries Show TAVR Evolution in UK, Internationally

Endoluminal Sciences: A New Concept for Eliminating Paravalvular Regurgitation

A Novel Balloon-Expandable TAVR System for Aortic Regurgitation

TCT-97. Three-dimensional Echocardiographic Measurements of the Aortic Annulus Predict Paravavular Regurgitation Following Transcatheter Aortic Valve Replacement

TCT-92. Does Mitral Regurgitation Impact the Outcome of TAVI Procedures? Insights from the FRANCE2 Registry

TCT-91. Peri-valvular Aortic Regurgitation in Balloon-expendable and Self-expendable TAVI procedures: Predictors and Impact on Clinical Outcome - Insights from the FRANCE2 Registry

Neovasc's Tiara™ transcatheter mitral valve selected as a best new device concept at TCT 2012 Scientific Symposium

Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami

Reduces Paravalvular Regurgitation

Paravalvular Regurgitation as a Strong Predictor of Post-TAVR Mortality

Moderate or Severe Mitral Regurgitation and Aortic Stenosis: Surgery or TAVR?

3-D Annulus Sizing (using MSCT or 3-D Echo) Is Now the Gold Standard and Helps to Reduce Paravalvular Regurgitation After TAVR

Review of TAVR Use Offers Significant Advances, Positive Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content